Prevalence, epidemiology and clinical outcome of Candida auris infections: Experience from a tertiary care hospital in Jaipur-Reference-Cited by-同舟云学术

Prevalence, epidemiology and clinical outcome of Candida auris infections: Experience from a tertiary care hospital in Jaipur

Published:2021-07-12 Issue:4 Volume:51 Page:508-513
ISSN:0049-4755
Container-title:Tropical Doctor
language:en
Short-container-title:Trop Doct

Author:

Bacchani Daisy¹,Rajni Ekadashi²^ORCID,Garg Vishnu K³^ORCID,Sharma Richa⁴,Mamoria Ved P⁵

Affiliation:

1. Resident, Department of Microbiology, Mahatma Gandhi University of Medical Science & Technology, Jaipur, India

2. Associate Professor, Department of Microbiology, Mahatma Gandhi University of Medical Science & Technology, Jaipur, India

3. Assistant Professor, Department of Anesthesia, Mahatma Gandhi University of Medical Science & Technology, Jaipur, India

4. Assistant Professor, Department of Microbiology, Mahatma Gandhi University of Medical Science & Technology, Jaipur, India

5. Professor and Head of Department, Mahatma Gandhi University of Medical Science & Technology, Jaipur, India

Abstract

Candida auris is identified as an emerging pathogen worldwide. It is multidrug resistant and causes invasive healthcare-associated infections. Our retrospective study was conducted to determine the prevalence and epidemiology of C. auris infections in a tertiary care hospital in Jaipur. 24 clinical C. auris strains were included, most being from urine. The majority patients needed intensive care and had at least one underlying co-morbid condition. A history of broad-spectrum antibiotic or antifungal usage was present in 85%. Fluconazole, voriconazole, amphotericin B and 5-fluorocytosine resistance was seen in 96, 42, 33 and 8% isolates respectively. No echinocandin resistance was noted.

Publisher

SAGE Publications

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://journals.sagepub.com/doi/pdf/10.1177/00494755211028685

Reference7 articles.

1. What’s new on emerging resistant Candida species

2. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris

3. The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic

4. Candida auris: An emerging pathogen “incognito”?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview about Candida auris: What's up 12 years after its first description?;Journal of Medical Mycology;2022-05